This inventor holds 2 USPTO granted patents. Top assignee: Microdose Therapeutx, Inc.. Active years: 2015-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2016
Title: The Innovations of Eugene R. Reynolds
Introduction
Eugene R. Reynolds is a notable inventor based in Scotch Plains, NJ (US). He has made significant contributions to the field of medical research, particularly in the treatment of respiratory diseases. With a total of 2 patents, his work focuses on innovative compositions and methods that address critical health issues.
Latest Patents
Reynolds' latest patents include groundbreaking advancements in the treatment and prevention of pneumovirus infections. One of his notable inventions provides novel crystalline polymorphic forms of MDT-637. These forms possess physicochemical properties specifically suited for drug production, including amorphous formation and composite form. The polymorphs described in his patents are particularly useful for treating respiratory diseases, such as those caused by respiratory syncytial virus.
Career Highlights
Eugene R. Reynolds has established a successful career in the pharmaceutical industry. He is currently associated with Microdose Therapeutx, Inc., where he continues to innovate and develop new therapeutic solutions. His work has the potential to significantly impact the treatment of respiratory illnesses, showcasing his dedication to improving public health.
Collaborations
Throughout his career, Reynolds has collaborated with esteemed colleagues, including Robert Owen Cook and Boris Shekunov. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the medical field.
Conclusion
Eugene R. Reynolds exemplifies the spirit of innovation in the medical research sector. His contributions through patents and collaborations highlight his commitment to advancing treatments for respiratory diseases. His work continues to inspire future advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
